AU Patent

AU2009234322B2 — Oligomer-aryloxy-substituted propanamine conjugates

Assigned to Nektar Therapeutics · Expires 2014-12-04 · 11y expired

What this patent protects

The invention relates to (among other things) oligomer- aryloxy-substituted propanamine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated aryloxy-substituted propan…

USPTO Abstract

The invention relates to (among other things) oligomer- aryloxy-substituted propanamine conjugates and related compounds. A conjugate of the invention, when administered by any of a number of administration routes, exhibits advantages over un-conjugated aryloxy-substituted propanamine compounds.

Drugs covered by this patent

Patent Metadata

Patent number
AU2009234322B2
Jurisdiction
AU
Classification
—
Expires
2014-12-04
Drug substance claim
No
Drug product claim
No
Assignee
Nektar Therapeutics
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.